Covered recipient · General Payments record
PAMELA J BARTELL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,390.17
- Reported across 521 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $816.47 | 50 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $388.70 | 25 |
| Lilly USA, LLC | $100.32 | 6 |
| Amgen Inc. | $57.39 | 4 |
| Teva Pharmaceuticals USA, Inc. | $46.00 | 2 |
| Inspire Medical Systems, Inc. | $42.78 | 2 |
| PFIZER INC. | $34.09 | 2 |
| Novo Nordisk AS | $31.46 | 2 |
| TOLMAR, INC. | $21.31 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $20.99 | 1 |
| Antares Pharma, Inc. | $16.95 | 1 |
| Actelion Pharmaceuticals US, Inc. | $15.52 | 1 |
| Esperion Therapeutics, Inc. | $13.96 | 1 |
| Acerta Pharma LLC | $13.66 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (50)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.90 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285501 | CMS |
| ABBVIE INC. | $17.30 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285503 | CMS |
| ABBVIE INC. | $18.36 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285505 | CMS |
| ABBVIE INC. | $17.12 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285507 | CMS |
| ABBVIE INC. | $5.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285509 | CMS |
| ABBVIE INC. | $17.11 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285511 | CMS |
| ABBVIE INC. | $21.15 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285513 | CMS |
| ABBVIE INC. | $18.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285515 | CMS |
| ABBVIE INC. | $3.72 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285517 | CMS |
| ABBVIE INC. | $11.50 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285519 | CMS |
| ABBVIE INC. | $27.53 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285521 | CMS |
| ABBVIE INC. | $8.05 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285523 | CMS |
| ABBVIE INC. | $4.37 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285525 | CMS |
| ABBVIE INC. | $18.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285527 | CMS |
| ABBVIE INC. | $18.54 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285529 | CMS |
| ABBVIE INC. | $26.73 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285531 | CMS |
| ABBVIE INC. | $18.86 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285533 | CMS |
| ABBVIE INC. | $19.17 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285535 | CMS |
| ABBVIE INC. | $14.00 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285537 | CMS |
| ABBVIE INC. | $20.65 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285539 | CMS |
| ABBVIE INC. | $11.93 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285541 | CMS |
| ABBVIE INC. | $11.67 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285543 | CMS |
| ABBVIE INC. | $17.68 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285545 | CMS |
| ABBVIE INC. | $22.68 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285547 | CMS |
| ABBVIE INC. | $6.99 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103285549 | CMS |
| Actelion Pharmaceuticals US, Inc. | $15.52 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078922409 | CMS |
| Amgen Inc. | $13.70 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117502244 | CMS |
| Amgen Inc. | $14.55 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117502246 | CMS |
| Amgen Inc. | $15.60 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117502248 | CMS |
| Amgen Inc. | $13.54 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117502250 | CMS |
| Antares Pharma, Inc. | $16.95 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146448716 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.66 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104497698 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.34 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117978014 | CMS |
| Boston Scientific Corporation | $20.99 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092344836 | CMS |
| Esperion Therapeutics, Inc. | $13.96 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129427508 | CMS |
| Inspire Medical Systems, Inc. | $15.45 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148042162 | CMS |
| Inspire Medical Systems, Inc. | $27.33 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148042164 | CMS |
| Lilly USA, LLC | $15.84 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135270241 | CMS |
| Lilly USA, LLC | $13.30 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135258600 | CMS |
| Lilly USA, LLC | $18.74 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135304441 | CMS |
| Lilly USA, LLC | $17.16 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135314918 | CMS |
| Lilly USA, LLC | $17.99 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135304446 | CMS |
| Lilly USA, LLC | $17.29 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135274487 | CMS |
| Novo Nordisk Inc | $16.03 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097275558 | CMS |
| Novo Nordisk Inc | $15.43 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097148452 | CMS |
| PFIZER INC. | $13.44 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131260262 | CMS |
| PFIZER INC. | $20.65 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131061379 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.63 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151721480 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.37 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151721502 | CMS |
| Tolmar, Inc. | $21.31 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138716326 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.